نتایج جستجو برای: t cell vaccination

تعداد نتایج: 2220123  

2013
Lana E Kandalaft Cheryl Chiang Emese Zsiros Janos Tanyi Daniel Powell Rosemarie Mick George Coukos

Novel therapeutic strategies are warranted in recurrent ovarian cancer. We report two independent consecutive studies of combinatorial immunotherapy comprising dendritic cell (DC)-based autologous whole tumor antigen vaccination in combination with antiangiogenesis therapy. 31 patients with recurrent progressive stage III and IV ovarian cancer with available tumor lysate from secondary debulkin...

2003
JC Cerottini Daniel E. Speiser Donata Rimoldi Pascal Batard Danielle Liénard Ferdy Lejeune Jean-Charles Cerottini Pedro Romero

Tumor vaccines may induce activation and expansion of specific CD8 T cells which can subsequently destroy tumor cells in cancer patients. This phenomenon can be observed in approximately 5-20% of vaccinated melanoma patients. We searched for factors associated with T cell responsiveness to peptide vaccines. Peptide antigen-specific T cells were quantified and characterized ex vivo before and af...

Journal: :Cancer research 2010
Chris Schiering Jlenia Guarnerio Veronica Basso Luca Muzio Anna Mondino

CD4(+) T cells play a central role in protective immunity. In a mouse tumor model, we previously found that tumor growth elicits natural CD4(+) T-cell responses, but impedes therapeutic vaccination. We show here that inhibition of vaccine-mediated naïve T-cell priming is due to the presence of a minor but distinct population of tumor-reactive CD4(+) T cells. These cells are generated in the tum...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2010
Nhat-Long L Pham Lecia L Pewe Courtney J Fleenor Ryan A Langlois Kevin L Legge Vladimir P Badovinac John T Harty

The number of memory CD8 T cells generated by infection or vaccination correlates strongly with the degree of protection observed in infection and tumor models. Therefore, rapid induction of protective numbers of effector and memory CD8 T cells may be crucial in the case of malignancy, pandemic infection, or bioterrorism. Many studies have shown that amplifying T-cell numbers by prime-boost vac...

Journal: :Journal of immunology 2011
Teresa Manzo Rodrigo Hess Michelini Veronica Basso Alessia Ricupito Jian-Guo Chai Elizabeth Simpson Matteo Bellone Anna Mondino

Transplantation of allogeneic hematopoietic stem cells with or without immunocompetent lymphocytes has proved a successful strategy in the treatment of hematological malignancies. We have recently shown that this approach can also cure mouse prostate cancer, provided that it is combined with tumor-specific vaccination. Whether the response to alloantigens acts by providing helper function to en...

2015
Danielle N. Renner Fang Jin Adam J. Litterman Alexis J. Balgeman Lisa M. Hanson Jeffrey D. Gamez Michael Chae Brett L. Carlson Jann N. Sarkaria Ian F. Parney John R. Ohlfest Istvan Pirko Kevin D. Pavelko Aaron J. Johnson

Glioblastoma (GBM) is among the most invasive and lethal of cancers, frequently infiltrating surrounding healthy tissue and giving rise to rapid recurrence. It is therefore critical to establish experimental model systems and develop therapeutic approaches that enhance anti-tumor immunity. In the current study, we have employed a newly developed murine glioma model to assess the efficacy of a n...

Journal: :Journal of immunology 2007
W Scott Webster R Houston Thompson Kimberley J Harris Xavier Frigola Susan Kuntz Brant A Inman Haidong Dong

Development of effective vaccination approaches to treat established tumors represents a focus of intensive research because such approaches offer the promise of enhancing immune system priming against tumor Ags via restimulation of pre-existing (memory) antitumoral helper and effector immune cells. However, inhibitory mechanisms, which function to limit the recall responses of tumor-specific i...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید